Biopharmaceutical Company-Herborium Group Reports-Phase 2 Clinical Trial-Mycobacteria

Med Centro Becomes First SuccessEHS Client to Go Live in Puerto Rico

BIRMINGHAM, Ala., June 27, 2012 /PRNewswire/ -- On June 5, 2012, Med Centro became the first SuccessEHS client in Puerto Rico to go live with the SuccessEHS solution, expanding the vendor's existing coverage in 48 states and the Virgin Islands.The go-live on June 5 took place... read more..

source:http://www.pharmainfo.net

Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease

MONMOUTH JUNCTION, N.J., June 27, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the first patient has been dosed in the Company's U.S. phase 2 clinical study of ARIKACE® (liposomal amikacin for inhalation) in... read more..

source:http://www.pharmainfo.net

Herborium Group Reports Record 6 Month Revenues

FORT LEE, N.J., June 27, 2012 /PRNewswire/ -- Herborium Group, Inc., ( HBRM) www.herborium.com, a Botanical Therapeutics® Company announces today that its revenues   from AcnEase®, all botanical, proprietary acne treatment, grew over 25 percent in  the first ... read more..

source:http://www.pharmainfo.net

Teva Pharmaceutical Industries Ltd-Medical Device Company-Cancer Pharmaceuticals

InspireMD Announces Enrollment Completion In Master Trial

TEL AVIV, Israel, May 24, 2012 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial... read more..

source:http://www.pharmainfo.net

Nanosmart(R) Pharmaceuticals Welcomes New Vice President Of R&D

ORANGE COUNTY, Calif., May 24, 2012 /PRNewswire/ -- Dr. James Smith, President of NanoSmart Pharmaceuticals, Inc., a California corporation developing a novel drug-delivery platform for cancer pharmaceuticals, announced today that the company has added Dr. Paul Glidden as Vice... read more..

source:http://www.pharmainfo.net

Teva Jumps as New CEO Jeremy Levin Set to Give Guidance Update

Teva Jumps as New CEO Jeremy Levin Set to Give Guidance Update
Bloomberg - 15 minutes ago
Teva Pharmaceutical Industries Ltd. (TEVA) rose the most in almost two months before new Chief Executive Officer Jeremy Levin gives an update on financial guidance. read more..

source:http://www.pharmainfo.net

Utilization Management-Fractional Resurfacing-Global Market Leader-Aesthetic Treatments

Specialty pharmacy utilization management proves effective

SAN FRANCISCO, April 19, 2012 /PRNewswire/ -- Utilization management (UM) programs such as prior authorizations (PAs) can be used to improve safety and efficacy as well as cost-effectiveness for specialty drugs, according to two new studies being presented tomorrow by Prime... read more..

source:http://www.pharmainfo.net

Solta Medical's Clear + Brilliant™ Resurfacing Device Demonstrates Significant Reduction of Pore Count and Pore Size

HAYWARD, Calif., April 19, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and a global market leader in aesthetic treatments, today announced the results of a first-of-its-kind, IRB-approved clinical study that evaluated the use of its... read more..

source:http://www.pharmainfo.net

InterMune To Release First Quarter Financial Results On April 26

BRISBANE, Calif., April 19, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its first quarter 2012 financial results at the close of the U.S. markets on Thursday, April 26, 2012.  A live conference call and webcast will be hosted by... read more..

source:http://www.pharmainfo.net

Giornata Internazionale Della Donna-Stigmatizzazione-Positive Action-Prnewswire

Women for Positive Action - mit neuem Informationsmaterial aktiv gegen Stigmatisierung und Diskriminierung

LONDON, March 7, 2012 /PRNewswire/ --Anlässlich des Internationalen Frauentages am 8. März 2012 hat Women for Positive Action ein praktisches didaktisches "Werkzeug" veröffentlicht, um Frauen, die mit HIV leben, bei der Auseinandersetzung mit Stigmatisierung und... read more..

source:http://www.pharmainfo.net

Women for Positive Action lancia uno strumento pratico per sostenere le donne che vivono con HIV e sono vittime di stigmatizzazione e di discriminazione

LONDRA, March 7, 2012 /PRNewswire/ --Per celebrare la Giornata internazionale della donna (GID) (8 marzo 2012), l'iniziativa Women for Positive Action ha creato uno strumento pratico ed educativo che offre sostegno alle donne che vivono con HIV nell'affrontare le sfide della... read more..

source:http://www.pharmainfo.net

Women for Positive Action » lance un outil pratique pour soutenir les femmes vivant avec le VIH et confrontées à la stigmatisation et à la discrimination

LONDRES, March 7, 2012 /PRNewswire/ --A l'occasion de la Journée Internationale de la Femme (JIF) (8 mars 2012), Women for Positive Action a lancé un outil pratique et pédagogique ayant pour but d'aider  les femmes vivant avec le VIH à faire face à la... read more..

source:http://www.pharmainfo.net